106 related articles for article (PubMed ID: 30997718)
1. Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.
Paskaš S; Krajnović T; Basile MS; Dunđerović D; Cavalli E; Mangano K; Mammana S; Al-Abed Y; Nicoletti F; Mijatović S; Maksimović-Ivanić D
Mol Carcinog; 2019 Aug; 58(8):1362-1375. PubMed ID: 30997718
[TBL] [Abstract][Full Text] [Related]
2. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
Srirangam A; Mitra R; Wang M; Gorski JC; Badve S; Baldridge L; Hamilton J; Kishimoto H; Hawes J; Li L; Orschell CM; Srour EF; Blum JS; Donner D; Sledge GW; Nakshatri H; Potter DA
Clin Cancer Res; 2006 Mar; 12(6):1883-96. PubMed ID: 16551874
[TBL] [Abstract][Full Text] [Related]
3. Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells.
Csekes E; Vágvölgyi M; Hunyadi A; Račková L
Life Sci; 2020 Nov; 260():118419. PubMed ID: 32931795
[TBL] [Abstract][Full Text] [Related]
4. Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.
Paskas S; Mazzon E; Basile MS; Cavalli E; Al-Abed Y; He M; Rakocevic S; Nicoletti F; Mijatovic S; Maksimovic-Ivanic D
Invest New Drugs; 2019 Oct; 37(5):1014-1028. PubMed ID: 30706336
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin rises reactive oxygen species levels and induces senescence in human melanoma cells by activation of p53/p21 pathway.
Guterres FA; Martinez GR; Rocha ME; Winnischofer SM
Exp Cell Res; 2013 Nov; 319(19):2977-88. PubMed ID: 23933099
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
7. HIV Protease Inhibitors Apoptotic Effect in SH-SY5Y Neuronal Cell Line.
Tricarico PM; de Oliveira Franca RF; Pacor S; Ceglia V; Crovella S; Celsi F
Cell Physiol Biochem; 2016; 39(4):1463-70. PubMed ID: 27607424
[TBL] [Abstract][Full Text] [Related]
8. Acrylamide Induces Senescence in Macrophages through a Process Involving ATF3, ROS, p38/JNK, and a Telomerase-Independent Pathway.
Kim KH; Park B; Rhee DK; Pyo S
Chem Res Toxicol; 2015 Jan; 28(1):71-86. PubMed ID: 25531190
[TBL] [Abstract][Full Text] [Related]
9. Impact of CCR5, integrase and protease inhibitors on human endothelial cell function, stress, inflammation and senescence.
Afonso P; Auclair M; Caron-Debarle M; Capeau J
Antivir Ther; 2017; 22(8):645-657. PubMed ID: 28350300
[TBL] [Abstract][Full Text] [Related]
10. The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes.
Grigem S; Fischer-Posovszky P; Debatin KM; Loizon E; Vidal H; Wabitsch M
Horm Metab Res; 2005 Oct; 37(10):602-9. PubMed ID: 16278782
[TBL] [Abstract][Full Text] [Related]
11. Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin.
Auclair M; Afonso P; Capel E; Caron-Debarle M; Capeau J
Antivir Ther; 2014; 19(8):773-82. PubMed ID: 24535489
[TBL] [Abstract][Full Text] [Related]
12. An integrated approach for monitoring cell senescence.
Pospelova TV; Chitikova ZV; Pospelov VA
Methods Mol Biol; 2013; 965():383-408. PubMed ID: 23296673
[TBL] [Abstract][Full Text] [Related]
13. Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6.
Yoshida A; Lee EK; Diehl JA
Cancer Res; 2016 May; 76(10):2990-3002. PubMed ID: 26988987
[TBL] [Abstract][Full Text] [Related]
14. PFG acted as an inducer of premature senescence in TIG-1 normal diploid fibroblast and an inhibitor of mitosis in the HeLa cells.
Huang Y; Ohno O; Miyamoto K
Biosci Biotechnol Biochem; 2019 Jun; 83(6):986-995. PubMed ID: 30836860
[TBL] [Abstract][Full Text] [Related]
15. Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir.
Fagone P; Mangano K; Quattrocchi C; Cavalli E; Mammana S; Lombardo GA; Pennisi V; Zocca MB; He M; Al-Abed Y; Nicoletti F
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):306-15. PubMed ID: 25903922
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
Ikezoe T; Hisatake Y; Takeuchi T; Ohtsuki Y; Yang Y; Said JW; Taguchi H; Koeffler HP
Cancer Res; 2004 Oct; 64(20):7426-31. PubMed ID: 15492266
[TBL] [Abstract][Full Text] [Related]
17. Effect of serum choice on replicative senescence in mesenchymal stromal cells.
Liu Y; Li YQ; Wang HY; Li YJ; Liu GY; Xu X; Wu XB; Jing YG; Yao Y; Wu CT; Jin JD
Cytotherapy; 2015 Jul; 17(7):874-84. PubMed ID: 25800776
[TBL] [Abstract][Full Text] [Related]
18. The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase-1 in DLD-1 colon carcinoma cells.
Mühl H; Paulukat J; Höfler S; Hellmuth M; Franzen R; Pfeilschifter J
Br J Pharmacol; 2004 Dec; 143(7):890-8. PubMed ID: 15504750
[TBL] [Abstract][Full Text] [Related]
19. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
20. Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells.
Li Z; Jiang K; Zhu X; Lin G; Song F; Zhao Y; Piao Y; Liu J; Cheng W; Bi X; Gong P; Song Z; Meng S
Cancer Lett; 2016 Jan; 370(2):332-44. PubMed ID: 26586345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
